Table 2.
Rest | End | ||||
---|---|---|---|---|---|
Type I | Type II | Type I | Type II | ||
[ATP] | Con | 21.6 ± 0.8 | 23.6 ± 1.3 | 22.3 ± 1.8 | 23.9 ± 2.0 |
CHO | 23.2 ± 1.3 | 22.6 ± 2.8 | 23.2 ± 1.2 | 23.6 ± 1.2 | |
[PCr] | Con | 66 ± 3 † | 80. ± 2 | 32. ± 6 | 32. ± 6 |
CHO | 67 ± 4 † | 78. ± 5 | 47 ± 4 ** | 48 ± 4 ** | |
[Glycogen] | Con | 304 ± 34 † | 403. ± 44 | 64. ± 2 | 175 ± 33 ‡ |
CHO | 290 ± 29 † | 423. ± 48 | 173 ± 13 ** | 221. ± 26 | |
[G-6-P] | Con | 0.6 ± 0.1 | 1.2 ± 0.6 | 1.5 ± 1.2 | 1.3 ± 0.8 |
CHO | 0.8 ± 0.2 | 1.8 ± 0.6 | 0.3 ± 0.1 | 0.5 ± 0.2 |
Values are means ± s.e.m. (n = 5), given in mmol glucosyl units (kg DM)-1 for glycogen and mmol (kg DM)-1 for other metabolites.
** Significantly different from Con (P < 0.05)
† significantly different from ‘Rest’ type II within the same treatment (P < 0.01)
‡ significantly different from ‘End’ type I within the same treatment (P < 0.05).